Zydus gets USFDA nod for Baclofen

MUMBAI: Zydus Cadila has received the final approval from USFDA to market Baclofen Tablets (US RLD- Lioresal) 10 mg and 20 mg. It will be manufactured at the group's formulations manufacturing facility at Baddi, says a company statement.

Baclofen is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury/disease. It works by helping to relax the muscles.

The group now has 234 approvals and has so far filed over 340 ANDAs since the commencement of the filing process in FY 2003-04.